GVK Biosciences along with Wyeth Research won the prestigious European Outsourcing Award 2009 for the Best New Partnership. The award was received by Manni Kantipudi, president, GVK Bio at a ceremony held at the Intercontinental Grand, Madrid, on October 14. GVK Bio-Wyeth came out as winners amongst several competing entries.

Earlier in the year, GVK Bio had filed its nominations under two categories 'Best New Product' and the 'Best New Partnership/Acquisition/Merger'. GVK Bio's entry for the 'Best New Product' was its innovative 'Clinical Biomarker Database' developed together with a Big Pharma and the US FDA. 'GVK Bio - Wyeth: Value co-creators' was GVK Bio's nomination for the 'Best New Partnership'. GVK Bio were declared finalists in both categories.

"We are delighted to have won the Best New Partnership Award along with our partner, Wyeth Research. This award is a recognition of the dedication and commitment of our employees in understanding and delivering to our customers' expectations. We are proud that we have been considered alongside with Wyeth and thank them for their faith and commitment to this collaboration," said Manni Kantipudi.

The nomination for the Best New Partnership was put together by GVK Bio and Wyeth. It covered the GVK Bio-Wyeth trendsetting deal of 150 synthetic chemistry deal in 2006, further expansion of the collaboration to chemoinformatics and modelling. In 2008, Wyeth and GVK Bio entered into a collaboration based on a risk sharing model to identify and optimize lead series.

European Outsourcing Awards were launched in 2005. It recognizes the new and significant developments in contract services and reward successful companies for their outstanding contributions throughout the year. The Awards recognize excellence in R&D, marketing, business and technology across the pharmaceutical outsourcing, biopharmaceutical and clinical trial sectors. The awards function is alongside the annual CPhI/ICSE/PMEC.